143 related articles for article (PubMed ID: 32769428)
21. An 8-Year-Old Child with Malignant Deciduoid Mesothelioma of the Abdomen: Report of a Case and Review of the Literature.
Wolff-Bar M; Dujovny T; Vlodavsky E; Postovsky S; Morgenstern S; Braslavsky D; Nissan A; Steinberg R; Feinmesser M
Pediatr Dev Pathol; 2015; 18(4):327-30. PubMed ID: 25856259
[TBL] [Abstract][Full Text] [Related]
22. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
23. Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study.
Kepenekian V; Elias D; Passot G; Mery E; Goere D; Delroeux D; Quenet F; Ferron G; Pezet D; Guilloit JM; Meeus P; Pocard M; Bereder JM; Abboud K; Arvieux C; Brigand C; Marchal F; Classe JM; Lorimier G; De Chaisemartin C; Guyon F; Mariani P; Ortega-Deballon P; Isaac S; Maurice C; Gilly FN; Glehen O;
Eur J Cancer; 2016 Sep; 65():69-79. PubMed ID: 27472649
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma: Experience of a Peritoneal Surface Malignancy Center.
Aydin N; Sardi A; Milovanov V; Nieroda C; Sittig M; Nunez MF; Jimenez W; Gushchin V
Am Surg; 2015 Dec; 81(12):1253-9. PubMed ID: 26736164
[TBL] [Abstract][Full Text] [Related]
25. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal Mesothelioma-An Update.
Malpica A
Adv Anat Pathol; 2023 Jul; 30(4):262-274. PubMed ID: 36729766
[TBL] [Abstract][Full Text] [Related]
27. Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesothelioma Undergoing Operative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy.
Li YC; Khashab T; Terhune J; Eckert RL; Hanna N; Burke A; Richard Alexander H
Ann Surg Oncol; 2017 Aug; 24(8):2259-2265. PubMed ID: 28324285
[TBL] [Abstract][Full Text] [Related]
28. Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study.
Baratti D; Kusamura S; Cabras AD; Deraco M
Ann Surg Oncol; 2012 May; 19(5):1416-24. PubMed ID: 22302266
[TBL] [Abstract][Full Text] [Related]
29. [Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia].
Gómez Portilla A; Cendoya I; Muriel J; Olabarria I; Guede N; Moraza N; Fernández E; Martínez de Lecea C; Magrach L; Martín E; Romero E; Aguado I; Valdovinos M; Larrabide I
Cir Esp; 2007 Feb; 81(2):82-6. PubMed ID: 17306123
[TBL] [Abstract][Full Text] [Related]
30. Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases.
Pavlisko EN; Roggli VL
Am J Surg Pathol; 2015 Nov; 39(11):1568-75. PubMed ID: 26371785
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive review of childbearing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Papageorgiou D; Manatakis DK; Papakonstantinou K; Kyriazanos ID
Arch Gynecol Obstet; 2020 Oct; 302(4):793-799. PubMed ID: 32653946
[TBL] [Abstract][Full Text] [Related]
32. Mesothelioma In Situ Mimicking Well-differentiated Papillary Mesothelial Tumor.
Galateau-Salle F; Hamilton T; MacNeill A; Hofman V; Sequeiros R; Sagan C; Le Stang N; Churg A
Am J Surg Pathol; 2023 May; 47(5):611-617. PubMed ID: 36876759
[TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.
Teo MC; Tan GH; Tham CK; Lim C; Soo KC
Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144
[TBL] [Abstract][Full Text] [Related]
34. Malignant mesothelioma in situ: morphologic features and clinical outcome.
Churg A; Galateau-Salle F; Roden AC; Attanoos R; von der Thusen JH; Tsao MS; Chang N; De Perrot M; Dacic S
Mod Pathol; 2020 Feb; 33(2):297-302. PubMed ID: 31375770
[TBL] [Abstract][Full Text] [Related]
35. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors.
Goldblum J; Hart WR
Am J Surg Pathol; 1995 Oct; 19(10):1124-37. PubMed ID: 7573671
[TBL] [Abstract][Full Text] [Related]
36. Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis.
Benzerdjeb N; Dartigues P; Kepenekian V; Valmary-Degano S; Mery E; Avérous G; Chevallier A; Laverriere MH; Villa I; Harou O; Sallé FG; Villeneuve L; Glehen O; Isaac S; Hommell-Fontaine J; Bibeau F;
Virchows Arch; 2021 Oct; 479(4):765-772. PubMed ID: 33855595
[TBL] [Abstract][Full Text] [Related]
37. Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.
Marchevsky AM; Khoor A; Walts AE; Nicholson AG; Zhang YZ; Roggli V; Carney J; Roden AC; Tazelaar HD; Larsen BT; LeStang N; Chirieac LR; Klebe S; Tsao MS; De Perrot M; Pierre A; Hwang DM; Hung YP; Mino-Kenudson M; Travis W; Sauter J; Beasley MB; Galateau-Sallé F
Mod Pathol; 2020 Feb; 33(2):281-296. PubMed ID: 31485011
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray.
Deraco M; Cabras A; Baratti D; Kusamura S
Ann Surg Oncol; 2015 Dec; 22(13):4344-51. PubMed ID: 25777091
[TBL] [Abstract][Full Text] [Related]
39. Primary Malignant Deciduoid Mesothelioma: A Challenging Diagnosis.
Regragui M; Guebessi NB
Arch Pathol Lab Med; 2019 Apr; 143(4):531-533. PubMed ID: 30500290
[TBL] [Abstract][Full Text] [Related]
40. Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry.
Vogin G; Hettal L; Vignaud JM; Dartigues P; Goere D; Ferron G; Heyd B; Bereder JM; Tuech JJ; Glehen O; de Chaisemartin C; Lherm Y; Villeneuve L; Kepenekian V; Marchal F;
Ann Surg Oncol; 2019 Mar; 26(3):852-860. PubMed ID: 30635798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]